Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2024 · 53 positions · Total reported value $1.01B · Top-10 concentration 53.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, Logos Global Management LP disclosed 53 equity positions with a combined reported value of $1.01B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were ALNY ($74.72M), IDYA ($65.82M), IMCR ($58.50M). By sector, the heaviest allocations are Health Care 86.1%, Other 13.9%. Versus the prior quarter, allocation shifted toward Health Care (+10.8pp) and away from Other (-10.8pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 39% of names.

The largest new positions opened in Q1 2024 were ALNY ($74.72M), GERN ($29.70M), CLDX ($27.28M).

Of the 20 positions fully exited versus the prior quarter, the largest were ARGX ($55.16M), RYZB ($35.32M), AMAM ($29.90M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • ALNY ALNYLAM PHARMACEUTICALS INC · $74.72M
  • GERN GERON CORP · $29.70M
  • CLDX CELLDEX THERAPEUTICS INC NEW · $27.28M
  • VERA VERA THERAPEUTICS INC · $24.79M
  • ADVM ADVERUM BIOTECHNOLOGIES INC · $21.21M
  • CYBN CYBIN INC · $16.54M
  • XNCR XENCOR INC COM · $14.38M
  • CGON CG ONCOLOGY INC · $13.17M

Fully Exited (vs previous quarter)

  • ARGX ARGENX SE · prev qtr: $55.16M
  • RYZB RAYZEBIO INC · prev qtr: $35.32M
  • AMAM AMBRX BIOPHARMA INC · prev qtr: $29.90M
  • KRTX KARUNA THERAPEUTICS INC · prev qtr: $28.49M
  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $10.39M
  • RVMD REVOLUTION MEDICINES INC · prev qtr: $10.04M · history
  • MOR MORPHOSYS AG · prev qtr: $9.90M
  • SLRN ACELYRIN INC · prev qtr: $9.32M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 86.1%
Other 13.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 500.00K $74.72M 7.40%
7.40%
New
2 1.50M $65.82M 6.52%
6.52%
Reduce
3 900.00K $58.50M 5.79%
5.79%
Add
4 1.77M $57.35M 5.68%
5.68%
Add
5 5.81M $51.99M 5.15%
5.15%
Add
6 400.00K $51.78M 5.13%
5.13%
Reduce
7 4.38M $49.63M 4.91%
4.91%
Hold
8 1.73M $49.11M 4.86%
4.86%
Reduce
9 800.00K $47.02M 4.66%
4.66%
Reduce
10 1.30M $35.02M 3.47%
3.47%
Add
11 1.48M $31.09M 3.08%
3.08%
Add
12 9.00M $29.70M 2.94%
2.94%
New
13 650.00K $27.28M 2.70%
2.70%
New
14 1.57M $26.41M 2.62%
2.62%
Add
15 575.00K $24.79M 2.46%
2.46%
New
16 1.50M $21.21M 2.10%
2.10%
New
17 5.03M $20.28M 2.01%
2.01%
Hold
18 800.00K $20.21M 2.00%
2.00%
Hold
19 450.00K $19.29M 1.91%
1.91%
Reduce
20 40.00M $16.54M 1.64%
1.64%
New
21 650.00K $14.38M 1.42%
1.42%
New
22 1.00M $14.07M 1.39%
1.39%
Add
23 300.00K $13.17M 1.30%
1.30%
New
24 800.00K $12.88M 1.28%
1.28%
New
25 500.00K $12.42M 1.23%
1.23%
New
26 700.00K $12.26M 1.21%
1.21%
Add
27 700.00K $11.93M 1.18%
1.18%
New
28 1.00M $10.51M 1.04%
1.04%
New
29 250.00K $9.48M 0.94%
0.94%
Add
30 1.00M $9.44M 0.94%
0.94%
Reduce
31 6.25M $9.25M 0.92%
0.92%
New
32 150.00K $9.15M 0.91%
0.91%
New
33 1.35M $8.98M 0.89%
0.89%
Reduce
34 350.00K $8.33M 0.82%
0.82%
New
35 2.20M $7.59M 0.75%
0.75%
New
36 1.00M $7.17M 0.71%
0.71%
Reduce
37 100.00K $7.01M 0.69%
0.69%
Reduce
38 300.00K $6.40M 0.63%
0.63%
New
39 382.35K $6.19M 0.61%
0.61%
Hold
40 3.10M $6.04M 0.60%
0.60%
Reduce
41 150.00K $5.65M 0.56%
0.56%
New
42 700.00K $5.31M 0.53%
0.53%
New
43 1.00M $5.13M 0.51%
0.51%
New
44 1.93M $4.29M 0.42%
0.42%
New
45 2.90M $3.65M 0.36%
0.36%
Hold
46 3.47M $3.01M 0.30%
0.30%
New
47 200.00K $2.85M 0.28%
0.28%
New
48 99.21K $2.27M 0.23%
0.23%
Reduce
49 257.98K $1.81M 0.18%
0.18%
Reduce
50 493.83K $854.32K 0.09%
0.09%
Hold

FAQ

What did Logos Global Management LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Logos Global Management LP reported 53 equity positions worth $1.01B in aggregate; its largest disclosed positions were ALNY ($74.72M), IDYA ($65.82M), IMCR ($58.50M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $1.01B of long equity holdings across 53 positions as of 2024-Q1. Top-10 holdings account for 53.6% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →